Acadia Pharmaceuticals Inc (ACAD)

Oct 14, 2025

Is ACADIA Pharmaceuticals Inc. stock trading near support levelsTrade Analysis Report & Expert-Curated Trade Recommendations - newser.com

Oct 14, 2025

Oct 14, 2025

How to track smart money flows in ACADIA Pharmaceuticals Inc.2025 Trading Volume Trends & Entry Point Confirmation Signals - newser.com

Oct 14, 2025

Oct 13, 2025

Real time alert setup for ACADIA Pharmaceuticals Inc. performancePortfolio Growth Summary & Real-Time Market Trend Scan - newser.com

Oct 13, 2025

Oct 13, 2025

Ranking ACADIA Pharmaceuticals Inc. among high performing stocks via toolsRisk Management & Advanced Technical Signal Analysis - newser.com

Oct 13, 2025

Oct 13, 2025

How sentiment analysis helps forecast ACADIA Pharmaceuticals Inc.Portfolio Value Report & Weekly Hot Stock Watchlists - newser.com

Oct 13, 2025

Oct 12, 2025

Applying Elliott Wave Theory to ACADIA Pharmaceuticals Inc.Weekly Loss Report & Risk Adjusted Swing Trade Ideas - newser.com

Oct 12, 2025

Oct 10, 2025

Why ACADIA Pharmaceuticals Inc. stock could be next big winnerTrade Volume Report & Safe Entry Zone Identification - newser.com

Oct 10, 2025

Oct 10, 2025

Leerink Partnrs Issues Optimistic Outlook for ACAD Earnings - MarketBeat

Oct 10, 2025

Oct 10, 2025

Heatmap analysis for ACADIA Pharmaceuticals Inc. and competitors2025 Pullback Review & Weekly Market Pulse Alerts - newser.com

Oct 10, 2025

Oct 10, 2025

How high can ACADIA Pharmaceuticals Inc. stock go2025 Institutional Moves & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 10, 2025

Oct 10, 2025

Detecting support and resistance levels for ACADIA Pharmaceuticals Inc.2025 Macro Impact & Verified Momentum Watchlists - newser.com

Oct 10, 2025

Oct 09, 2025

Using Bollinger Bands to evaluate ACADIA Pharmaceuticals Inc.July 2025 Momentum & AI Enhanced Execution Alerts - newser.com

Oct 09, 2025

Oct 08, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc.ACAD - PR Newswire

Oct 08, 2025

Oct 08, 2025

Q3 EPS Estimate for ACADIA Pharmaceuticals Cut by Analyst - MarketBeat

Oct 08, 2025

Oct 08, 2025

RBC Cuts Price Target on ACADIA Pharmaceuticals to $34 From $40, Keeps Outperform Rating - MarketScreener

Oct 08, 2025

Oct 07, 2025

Acadia Healthcare Company, Inc. Announces Chief Financial Officer Changes, Effective October 27, 2025 - MarketScreener

Oct 07, 2025

Oct 07, 2025

What drives ACADIA Pharmaceuticals Inc stock priceHead and Shoulders Patterns & Double Digit Capital Growth - earlytimes.in

Oct 07, 2025

Oct 06, 2025

How to interpret RSI for ACADIA Pharmaceuticals Inc. stockWeekly Risk Summary & Reliable Intraday Trade Alerts - newser.com

Oct 06, 2025

Oct 06, 2025

Real time social sentiment graph for ACADIA Pharmaceuticals Inc.Volume Spike & Weekly Chart Analysis and Trade Guides - newser.com

Oct 06, 2025

Oct 06, 2025

Detecting price anomalies in ACADIA Pharmaceuticals Inc. with AI2025 Price Action Summary & Weekly Chart Analysis and Trade Guides - newser.com

Oct 06, 2025

Oct 06, 2025

ACADIA Pharmaceuticals: Nuplazid And Daybue Are Enough To Remain Bullish (ACAD) - Seeking Alpha

Oct 06, 2025

Oct 06, 2025

Is ACADIA Pharmaceuticals Inc. stock attractive after correctionRate Hike & Weekly High Conviction Ideas - newser.com

Oct 06, 2025

Oct 06, 2025

Wealth Enhancement Advisory Services LLC Makes New $511,000 Investment in ACADIA Pharmaceuticals Inc. $ACAD - Defense World

Oct 06, 2025

Oct 05, 2025

Intraday pattern recognizer results for ACADIA Pharmaceuticals Inc.2025 Trading Recap & Technical Entry and Exit Alerts - newser.com

Oct 05, 2025

Oct 05, 2025

Using R and stats models for ACADIA Pharmaceuticals Inc. forecastingWall Street Watch & Reliable Intraday Trade Alerts - newser.com

Oct 05, 2025

Oct 05, 2025

News impact scoring models applied to ACADIA Pharmaceuticals Inc.2025 Sector Review & Stock Portfolio Risk Control - newser.com

Oct 05, 2025

Oct 05, 2025

What machine learning models say about ACADIA Pharmaceuticals Inc.Swing Trade & Expert Verified Stock Movement Alerts - newser.com

Oct 05, 2025

Oct 05, 2025

Will ACADIA Pharmaceuticals Inc. rebound enough to break even2025 Bull vs Bear & Weekly Breakout Watchlists - newser.com

Oct 05, 2025

Oct 04, 2025

Acadia Pharmaceuticals’ Investigational Drug For Rare Genetic Disorder Fails In Late-Stage Study - MSN

Oct 04, 2025

Oct 04, 2025

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Oct 04, 2025

Oct 03, 2025

ACADIA Pharmaceuticals Inc. Securities Lawsuit Investigation - Claim Depot

Oct 03, 2025

Oct 03, 2025

Using flow based indicators on ACADIA Pharmaceuticals Inc.Weekly Loss Report & High Conviction Trade Alerts - newser.com

Oct 03, 2025

Oct 03, 2025

A Look at Acadia Pharmaceuticals’s Valuation After Setback in Phase 3 Prader-Willi Trial - Sahm

Oct 03, 2025

Oct 03, 2025

Acadia Pharmaceuticals Presents Clinical Data from Across Multiple Therapeutic Programs at the 2025 International Congress of Parkinson’s Disease and Movement Disorders - BioSpace

Oct 03, 2025

Oct 03, 2025

Published on: 2025-10-03 03:21:29 - newser.com

Oct 03, 2025

Oct 03, 2025

Acadia to present pipeline updates at Parkinson’s congress By Investing.com - Investing.com Nigeria

Oct 03, 2025

Oct 02, 2025

Acadia, e-therapeutics unveil rebrands to better represent their drugmaking missions - Fierce Pharma

Oct 02, 2025

Oct 02, 2025

Acadia to present pipeline updates at Parkinson’s congress - Investing.com

Oct 02, 2025